首页> Cells> Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma.

Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alisa,Ageenko

第一单位： Institute of Chemical Biology and Fundamental Medicine Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave, 8, Novosibirsk 630090, Russia.

作者： Alisa,Ageenko ^[1] ; Natalia,Vasileva ^[2] ; Gaukhar,Yusubalieva ^[3] ; Aleksandra,Sen'kova ^[1] ; Alexander,Romashchenko ^[4] ; Ilya,Gubskiy ^[5] ; Fedor,Zabozlaev ^[3] ; Evgeniy,Zavyalov ^[4] ; Maya,Dymova ^[2] ; Vladimir,Richter ^[2] ; Elena,Kuligina ^[2]

作者单位： Institute of Chemical Biology and Fundamental Medicine Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave, 8, Novosibirsk 630090, Russia. ^[1] Institute of Chemical Biology and Fundamental Medicine Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave, 8, Novosibirsk 630090, Russia.;LLC "Oncostar", Inzhenernaya Str 23, Novosibirsk 630090, Russia. ^[2] Federal Research and Clinical Center of the Federal Medical and Biological Agency of Russia, Malaya Pirogovskaya Str 1a, Moscow 119435, Russia. ^[3] Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave, 10, Novosibirsk 630090, Russia. ^[4] Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Ostrovityanova Str 1, Moscow 117997, Russia.;Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency of Russia, Ostrovityanova Str 1, Moscow 117513, Russia. ^[5]

关键词 C6 glioma GL261 glioma oncolytic virus delivery virotherapy